Additional Prezista tablet strength available

Additional Prezista tablet strength available
Additional Prezista tablet strength available

Tibotec has launched Prezista 600mg (darunavir tablet) in addition to the 300mg dosage strength already available. Prezista, a protease inhibitor, is indicated for treating HIV infection in antiretroviral treatment-experienced adults when co-administered with ritonavir and other antiretroviral agents.

For more information call (877) REACH-TT or visit www.prezista.com.